
Wiley-Blackwell appoints Dr Charles Young
pharmafile | March 8, 2010 | Appointment | Medical Communications | Wiley, Wiley-Blackwell, appointment, medical communications
Dr Charles Young has joined Wiley-Blackwell as publishing director of global clinical solutions.
He moves to the company from the BMJ Group, where he was editor-in-chief of the clinical decision support products Best Practice and BMJ Point of Care, which he led since their launch.
He also edited the BMJ’s evidence-based medicine publication Clinical Evidence and previously worked as executive editor at The Lancet.
He is an emergency physician at St Thomas’ Hospital, London, where he will continue to practise, and teaches around the world on healthcare information topics.
Wiley-Blackwell is one of the largest health sciences publishers and Dr Young’s appointment will capitalise on its very strong presence in evidence-based medicine.
This encompasses its relationship with the Cochrane Collaboration, and the development of Essential Evidence Plus, the Health Economics and Evaluation Database and Evidence-Based Medicine Guidelines, which Dr Young will lead the development of as clinical decision support.
Related Content

PlasmidFactory founder Dr. Martin Schleef honoured with the NRW Innovation Award 2025
The founder and long-standing CEO of PlasmidFactory, Dr. Martin Schleef, was honoured in Düsseldorf with …

David Wheadon appointed to board of directors at Seaport Therapeutics
This week, Seaport Therapeutics have appointed David Wheadon MD to their board of directors.

Myeloma UK reveals new Director of Research appointment
UK non-profit organisation Myeloma UK has selected Sarah McDonald as its new Director of Research, …






